Acta Med. 2016, 59: 22-25
https://doi.org/10.14712/18059694.2016.51
Efficacy of Low-Dose Tocilizumab on Relapsing Adult-Onset Still’s Disease
References
1. Stillʼs disease in the adult. EG Ann Rheum Dis 1971; 30 (2): 121.
<https://doi.org/10.1136/ard.30.2.121>
<PubMed>
2. J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine 1991; 70(2): 118.
<https://doi.org/10.1097/00005792-199103000-00004>
3. AA, Leclerq SA, Yan A, Homik JE, Dinarello CA. Rapid Responses to anakinra in patients with refractory adult-onset Still’s disease. Arhtritis Rheum 2005; 52: 1974.
<https://doi.org/10.1002/art.21061>
4. H, Février J, Nicolle A, Auzary C, Geffray L. Tocilizumab in the treatment of the adult-onset Still’s disease : current clinical evidence. Clin Rheumatol 2013; 32: 141–147.
<https://doi.org/10.1007/s10067-012-2105-2>
5. F, Blanco R, Calvo-Rio V, et al. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still’s disease: a multicenter retrospective open-label study of thirty-four patients. Arthritis Rheumatol 2014; 66: 1659.
<https://doi.org/10.1002/art.38398>
6. Y, Gerfaud-Valentin M, Henry T, Sève P. Treatment of adult-onset Still’s disease: a review. Therapeutics and Clinical Risk Management 2015; 11: 33–43.
7. JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis Rheum 2006; 55(3): 420.
<https://doi.org/10.1002/art.21984>
8. B, Borget C, Rozenberg S, et al. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 1999; 26(2): 373.
9. S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 2010; 62: 2530–2535.
<https://doi.org/10.1002/art.27532>
10. M, Tada Y, Koarada S, et al. Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease. Mod Rheumatol 2009; 19: 57–63.
<https://doi.org/10.3109/s10165-008-0126-0>
11. H, Odani T, Shimizu Y, Takeda T, Kikuchi H. Usefulness of tacrolimus for refractory adult-onset Still’s disease: report of 6 cases. Mod rheumatol 2014; 18: 1–5.
<https://doi.org/10.3109/14397595.2014.933997>
12. AN, Peterson P, Sangle S, et al. Adult onset Still’s disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford) 2004 Jun; 43(6): 795–9.
<https://doi.org/10.1093/rheumatology/keh172>
13. T, Kishimoto T. Targeting Interleukin-6: All the way to treat autoimmune and inflammatory disease. Int J Biol Sci 2012; 8: 1227–1236.
<https://doi.org/10.7150/ijbs.4666>
<PubMed>
14. T, Ohta A,Yang D, et al. Elevated serum interleukin-6, interferon-gamma and tumor necrosis-alpha levels in patients with adult Still’s disease. J Rheumatol 1998; 25: 396–8.
15. Gotor J, Blanco Alonso R. Tocilizumab in rheumatoid arthritis. Rheumatol Clin 2011; 6: 29–32.
16. X, De Bandt M, Berthelot JM, et al. Tocilizumab in Refractory Adult Still’s Disease. Arthritis Care Research 2011; 1: 155–9.
<https://doi.org/10.1002/acr.20319>
17. P, Ruscitti P, Carubbi F, et al. Tocilizumab for the treatment of Adult-onset Still’s disease: Results from a case series. Clin Rheumatol 2014; 33: 49–55.
<https://doi.org/10.1007/s10067-013-2381-5>
18. O, Jiries N, Dranitzki Z, et al. Tocilizumab in adult-onset Still’s disease: The Israeli Experience. The Journal of Rheumatology 2014; 41: 244–247.
<https://doi.org/10.3899/jrheum.130881>
19. H, Mima T, Yoshio-Hoshino N, Matsushita M, Hashimoto J, Nishimoto N. A case report of a patient with refractory adult-onset Still’s disease who was succesfully treated with Tocilizumab over 6 years. Mod Rheumatol 2009; 19: 69–72.
<https://doi.org/10.3109/s10165-008-0116-2>
20. M, Nara H, Hirata D, Minota S. Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still’s disease. Arthritis Rheumat 2002; 46: 3388–9.
<https://doi.org/10.1002/art.10620>
